As of 2025-04-21, the Fair Value of Intellipharmaceutics International Inc (IPCI.TO) is -0.57 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.08 CAD, the upside of Intellipharmaceutics International Inc is -816.12%.
With the market price of 0.08 CAD and our fair value calculation, Intellipharmaceutics International Inc (IPCI.TO) is not a good investment. Investing in IPCI.TO stocks now will result in a potential loss of 816.12%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-11-30 | 2021-11-30 | 2022-11-30 | - | - | 5Y Avg | |
| Net income | -5.15 | -2.89 | - | - | -4.02 | |
| YoY growth | -51.73% | 43.78% | - | - | -3.97% | |
| Market Cap (mil) | 2.80 |
| P/E | |
| Forward P/E |
| EPS | -0.08 |
| Avg earnings growth rate | -3.97% |
| TTM earnings | -2.89 |